Fort Washington Investment Advisors Inc. OH Has $54.06 Million Stock Holdings in CVS Health Corporation $CVS

Key Points

• Fort Washington Investment Advisors Inc. OH reduced its stake in CVS Health Corporation by 13.3%, now holding 783,692 shares worth approximately $54.06 million.
• Several investors increased their stakes in CVS, indicating strong institutional interest, with 80.66% of the company's stock owned by institutional investors and hedge funds.
• CVS Health reported a quarterly EPS of $1.81, exceeding analysts' expectations, with revenue rising to $98.92 billion.

Fort Washington Investment Advisors Inc. OH lessened its stake in CVS Health Corporation (NYSE:CVS - Free Report) by 13.3% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 783,692 shares of the pharmacy operator's stock after selling 120,134 shares during the quarter. Fort Washington Investment Advisors Inc. OH owned 0.06% of CVS Health worth $54,059,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Essex Financial Services Inc. increased its stake in shares of CVS Health by 0.8% in the first quarter. Essex Financial Services Inc. now owns 20,705 shares of the pharmacy operator's stock valued at $1,403,000 after buying an additional 166 shares during the period. Williams Financial LLC increased its position in CVS Health by 2.5% during the 2nd quarter. Williams Financial LLC now owns 6,923 shares of the pharmacy operator's stock valued at $478,000 after purchasing an additional 167 shares during the period. Hemington Wealth Management increased its position in CVS Health by 33.7% during the 1st quarter. Hemington Wealth Management now owns 682 shares of the pharmacy operator's stock valued at $46,000 after purchasing an additional 172 shares during the period. Sumitomo Life Insurance Co. increased its position in CVS Health by 1.0% during the 1st quarter. Sumitomo Life Insurance Co. now owns 17,114 shares of the pharmacy operator's stock valued at $1,159,000 after purchasing an additional 174 shares during the period. Finally, Koshinski Asset Management Inc. increased its position in CVS Health by 3.7% during the 1st quarter. Koshinski Asset Management Inc. now owns 4,930 shares of the pharmacy operator's stock valued at $334,000 after purchasing an additional 178 shares during the period. Institutional investors and hedge funds own 80.66% of the company's stock.

Insider Activity

In other news, Director Anne A. Finucane sold 7,500 shares of the firm's stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the sale, the director directly owned 22,156 shares of the company's stock, valued at $1,573,519.12. This trade represents a 25.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.22% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

CVS has been the subject of a number of recent analyst reports. Cantor Fitzgerald reissued an "overweight" rating and set a $78.00 target price on shares of CVS Health in a research report on Tuesday, August 26th. Wolfe Research increased their price target on CVS Health from $80.00 to $85.00 and gave the stock an "outperform" rating in a report on Monday, September 22nd. Cowen restated a "buy" rating on shares of CVS Health in a report on Monday, August 4th. Barclays increased their price target on CVS Health from $80.00 to $87.00 and gave the stock an "overweight" rating in a report on Thursday, September 4th. Finally, Wall Street Zen upgraded CVS Health from a "hold" rating to a "buy" rating in a report on Sunday, September 21st. Two research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $78.25.

CVS Health Trading Up 1.6%

NYSE CVS opened at $75.80 on Friday. The firm has a market capitalization of $96.14 billion, a P/E ratio of 21.17, a PEG ratio of 0.84 and a beta of 0.62. The business has a fifty day simple moving average of $69.13 and a 200 day simple moving average of $66.99. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $77.34. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.46 by $0.35. The business had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.CVS Health's quarterly revenue was up 8.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. CVS Health's dividend payout ratio (DPR) is currently 74.30%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.